Scottish Medicines Consortium tiotropium (Spiriva Respimat)

following an abbreviated submission:

tiotropium (Spiriva® Respimat®) is accepted for use within NHSScotland.

Indication under review: as add-on maintenance bronchodilator treatment in patients aged 6 years and older with severe asthma who experienced one or more severe asthma exacerbations in the preceding year.

Tiotropium has been accepted for use in adult patients with asthma as add-on maintenance bronchodilator treatment.

To read more Press Release articles, click here.